跳至主要内容
临床试验/NL-OMON30879
NL-OMON30879已完成4 期

A prospective pediatric longitudinal evaluation to assess the long-term safety of tacrolimus ointment for the treatment of atopic dermatitis. - APPLES

Astellas Pharma0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • 1) Subject has/ had atopic dermatitis
  • 2) Subject has applied tacrolimus ointment 0.03% or 0.1% for at least 6 weeks either continuously or intermittently. This may include subjects who have been enrolled in previous tacrolimus ointments studies and or subjects with commercial product exposure prior to study enrollment.
  • 3) Subject age at first tacrolimus ointment exposure is /was < 16 years.
  • 4) Subject / caregiver has given written informed and assent.
  • 5) Subject / caregiver agrees to comply with the program requirements including an annual physical examination and biennal dermatological exam and agrees to be contacted and provide information.

排除标准

  • Not applicable

研究者

相似试验